| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 30 | |
| #2 | WIPO (World Intellectual Property Organization) | 7 | |
| #3 | United States | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Taiwan | 2 | |
| #8 | Brazil | 1 | |
| #9 | China | 1 | |
| #10 | Republic of Korea | 1 | |
| #11 | Mexico | 1 | |
| #12 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Peptides | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Radford Fleur | 7 |
| #2 | Knutsen Lars Jacob Stray | 7 |
| #3 | Fiumana Andrea | 7 |
| #4 | Hobbs Christopher John | 6 |
| #5 | Castile Jonathan David | 5 |
| #6 | Earnshaw Christopher Geoffrey | 5 |
| #7 | Birch Phillip John | 5 |
| #8 | Hayes Ann Gail | 5 |
| #9 | Watts Peter James | 5 |
| #10 | Akopian Armen Norakovitch | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB0514017D0 | Chemical compounds | |
| GB0514018D0 | Chemical compounds | |
| GB0500300D0 | Chemical compositions | |
| GB0420424D0 | Therapeutic compounds | |
| GB0407620D0 | Cell lines expressing VGSC, Nav1.8 | |
| WO2004087125A1 | Amino acid derivatives as inhibitors of mammalian sodium channels | |
| GB0403988D0 | Therapeutic compounds | |
| GB0330044D0 | Chemical compounds | |
| GB0320842D0 | Ion channel modulators | |
| GB0320293D0 | Chemical compounds | |
| GB0320294D0 | Chemical compounds | |
| WO2004017965A1 | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
| GB0318417D0 | Method and device | |
| GB0315874D0 | Chemical compounds | |
| GB0315872D0 | Chemical compounds | |
| GB0315140D0 | Therapeutic compounds | |
| GB0315139D0 | Chemical compounds | |
| GB0307632D0 | Chemical compounds | |
| GB0307633D0 | Chemical compounds | |
| GB0225041D0 | Pharmaceutical formulation |